Menu +
pharma.markets

Coronavirus: EU Commission lists key steps for effective vaccination strategies and vaccines deployment

As Europe learns to live with the pandemic, the development and swift global deployment of safe and effective vaccines against COVID-19 remains an essential element in the eventual solution to the public health crisis. In this context, the Commission is working to ensure that there will be access to safe vaccines across Europe, and encourages […]

Pfizer and BioNTech Announce New England Journal of Medicine Publication of Phase 1 Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that preliminary, peer-reviewed data from the Phase 1 portion of their ongoing U.S. study of BNT162b2 were published online in the New England Journal of Medicine (NEJM).   BNT162b2, which has advanced into a global Phase 3 study, is part of the companies’ mRNA-based […]

BioNTech to Present Data from BNT311 (GEN1046) and BNT131 (SAR441000) Programs at SITC 35th Annual Meeting

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that results from three clinical and preclinical studies have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting. The data represent the first clinical results from BioNTech’s ongoing collaborations with Genmab and Sanofi from both its mRNA and antibody […]

New Clinical Trial for a COVID-19 Vaccine Authorised in Germany

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has authorised another Phase-1 clinical trial of a vaccine against COVID-19 in Germany. The new vaccine candidate is a so-called vector vaccine. Trials on vaccine candidates in humans are a significant step in the direction of authorising safe and efficacious vaccines against COVID-19. This new vaccine is […]

BioNTech and Pfizer Announce Nature Publication of German Phase 1/2 Study Data from mRNA-based Vaccine Candidate BNT162b1 Against SARS-CoV-2

BioNTech SE (Nasdaq: BNTX) and Pfizer Inc. (NYSE: PFE) today announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2 Study of BNT162b1 were published online in the journal Nature. BNT162b1 is part of the companies’ mRNA-based vaccine development program Lightspeed against SARS-CoV-2. The preliminary clinical data from the German study of BNT162b1, a […]

BioNTech stock quote 18-9-2020

Company: BioNTechTicker: BNTXExchange: NASDAQLast Trade: $67.00Change: 0.22% Change: +0.33%Volume: 2,607,052Day’s High: $68.44Day’s Low: $65.17Previous Close: $66.78 Service provided by Intrado Digital Media, LLC

Bayer Launches Large-scale Pre-launch Trial of New Tomato Varieties with Resistance to Tomato Brown Rugose Fruit Virus (ToBRFV)

The trials, which begin late September in Mexico, will target two varieties of Roma tomatoes which show little or no symptoms of ToBRFV / Developing these varieties aligns with Bayer’s commitment to provide fruit and vegetable seeds from its Seminis and De Ruiter brands which help growers combat the challenges they face each season Bayer […]

Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™

Bayer has entered into an exclusive global license agreement with Systems Oncology, LLC, for ERSO™, a compound in pre-clinical development for the treatment of metastatic Estrogen Receptor-positive (ER+) breast cancer. ERSO is a small molecule activator of the Unfolded Protein Response (UPR) in ER+ breast cancer cells. ERSO’s differentiated mechanism of action offers significant potential […]

BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that it will receive a grant of up to 375 million Euro from an initiative by the German Federal Ministry of Education and Research (BMBF) to support the accelerated development of SARS-CoV-2 vaccines. BioNTech will use the milestone-based BMBF funding to support its contribution to […]

Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients

• Immunocompromised transplant patients are at risk of major complications when infected with BK virus • cobas BKV test addresses critical need for hospitals and laboratories to have standardised and comparable results across institutions • New Breakthrough Device test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus […]

State aid: EU Commission approves €199.45 million Italian support to compensate Alitalia for damages suffered due to coronavirus outbreak

The European Commission has found Italian €199.45 million support in favour of Alitalia to be in line with EU State aid rules. The measure aims at compensating the airline for the damages suffered due to the coronavirus outbreak. Executive Vice-President Margrethe Vestager, in charge of competition policy, said: “This measure will enable Italy to compensate […]

Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems

• First commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single sample • As COVID-19 and influenza infections can hardly be differentiated based on symptoms, healthcare professionals can confidently provide the right diagnosis and best course of treatment for patients • […]

Merck Places Hybrid Bond Amounting to €1.0 billion

Merck, a leading science and technology company, today successfully placed a hybrid bond amounting to €1.0 billion. The placement has a maturity of 60 years with an early redemption option for Merck after six years and a coupon of 1.625 % payable annually. In addition to the new issue, Merck also announced a cash tender […]

Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark, allowing fast triage decisions at point of care

• Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions • Antigen test accurately screens individuals with known exposure to infected SARS-CoV-2 patients, providing fast answers regarding their infection status • Affordable and small, instrument-free testing kit enables convenient use for healthcare professionals at […]

Influenza Season 2020/21 – First Vaccine Batches Released

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines started the annual batch release testing of influenza vaccines on 31 July 2020. In the meantime, the first 13,6 million doses have been released for German market. The batch testing is based on the strain adaptations approved by the Federal Institute or the EU Commission for the […]

Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality

• 2025 target to increase patients reached in LMICs with strategic innovative medicines by 200% and the Novartis Flagship Programs by 50% – bringing potential reach to over 23 million patients across these initiatives • Enhanced target for full carbon neutrality across all company operations and entire supply chain by 20301 • New collaboration with […]

Roche receives FDA approval for first HIV-1/HIV-2 Qualitative Test on the cobas 6800/8800 Systems in the fight against HIV/AIDS

• Detects, confirms and differentiates HIV-1 and HIV-2 infections providing clinicians with critical diagnostic data for personalised management of patients with HIV – from appropriate counseling on disease differences to targeted therapy • Supports rapid molecular detection of acute HIV infection, which is critical in curbing further disease transmission • Combines confirmatory HIV testing and […]

Merck today announced that it is launching a € 100,000 Community Involvement Initiative.

Performance Materials Launches € 100,000 Community Involvement Initiative Employees to engage in charitable projects in Asia, Africa and the United States A € 100,000 fund will support four social projects that help communities around the world Merck, a leading science and technology company, today announced that it is launching a € 100,000 Community Involvement Initiative. […]

Next Page »